Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
SPH3127-US-01 is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SPH3127 for the treatment of mild-to-moderate ulcerative colitis.
Epistemonikos ID: 6928dead135740fbe1fc912af4dd32d1fc7f2495
First added on: Mar 23, 2022